Education and Training
Ablation of Ventricular Fibrillation by Accurate Targeting of Arrhythmogenic Regions (AVATAR)
This study will test the hypothesis that many human heart rhythm disorders are caused by small localized sources, where brief ablation may successfully eliminate the heart rhythm disorder.
Stanford is currently accepting patients for this trial.
Stanford Investigator(s):
Eligibility
Inclusion Criteria:
1. Documented ventricular tachyarrhythmias.
2. Undergoing clinically indicated EP study with ablation.
Exclusion Criteria:
1. Unwillingness or inability to provide informed consent.
Ages Eligible for Study
21 Years - 90 Years
Genders Eligible for Study
All
Now accepting new patients
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Recruiting